Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001363035 | SCV001559117 | uncertain significance | RYR1-related disorder | 2021-08-20 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine with glutamine at codon 4681 of the RYR1 protein (p.Lys4681Gln). The lysine residue is highly conserved and there is a small physicochemical difference between lysine and glutamine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with RYR1-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002476653 | SCV002780837 | uncertain significance | Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; Congenital myopathy with fiber type disproportion; King Denborough syndrome | 2021-11-12 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004803660 | SCV005426507 | uncertain significance | Malignant hyperthermia, susceptibility to, 1 | 2024-08-06 | criteria provided, single submitter | clinical testing |